Blogs and updates

Patient recruitment can determine whether a clinical trial meets its enrollment goals, stays on schedule, and reaches the populations most relevant to the study. But effective recruitment is not simply about generating more leads. Sponsors need access to potentially eligible patients,...

Clinical trials require more than qualified investigators and access to potential participants. Each research site must also manage regulatory documentation, trained personnel, patient recruitment, protocol implementation, data collection, sponsor communication, and quality oversight. Coordinating these responsibilities across multiple locations can create...

Selecting the right research partner can directly influence site activation, patient recruitment, operational consistency, study quality, and overall trial performance. However, not all site management organizations for clinical trials provide the same level of infrastructure, patient access, or operational support. Some...

What Are Embedded Research Partners? Embedded research partners provide the infrastructure, personnel, systems, and operational support required to conduct clinical trials within existing healthcare practices. The objective is not simply to place a study inside a physician’s office. A successful embedded...

Clinical trial patient recruitment remains one of the most persistent operational challenges for pharmaceutical sponsors, biotechnology companies, and CROs. A study may have a strong protocol, experienced investigators, and adequate funding, yet still struggle to identify, enroll, and retain qualified participants....

Community clinic participation is redefining what effective clinical trial recruitment looks like in the United States. Sponsors who once defaulted to academic medical centers and standalone research facilities are now recognizing a fundamental truth: the patients who need access to trials...

For U.S. sponsors, biotech teams, and CRO leaders, selecting the right patient recruitment services is one of the highest-stakes decisions in clinical development. Enrollment delays are the leading cause of trial budget overruns, and the traditional site models that have long...

Oncology trial management demands a level of operational precision that separates generalist site networks from organizations built specifically for cancer research. Patient populations are medically complex, protocols are lengthy, dropout risk is high, and the regulatory bar for Phase I dose-escalation...

Clinical trial site networks are one of the most consequential decisions in study planning. Beyond regulatory compliance and infrastructure, sponsors and CROs increasingly evaluate a network’s ability to enroll diverse patient populations — a priority driven by FDA guidance, payer expectations,...

When we think about clinical trials, we often focus on the science — the compounds, the protocols, the endpoints. But behind every successful trial is something just as important: the people who participate in it. And not just any people —...

Clinical trial services for multi-site Phase 3 studies have evolved far beyond the traditional “build or buy” decision — and the hybrid insourced CRO model is leading that shift. Clinical trial services for multi-site Phase 3 studies have evolved far beyond...

Biotech sponsors evaluating a clinical trial partner for biotech programs face a crowded market. The right partner can mean the difference between hitting enrollment targets on schedule and watching timelines slip. This guide breaks down what to look for when selecting...